Designed for monitoring transplant patients undergoing Immunosuppression. A.I.D’s TranSpot ELISpot assay offers a combined tool for efficient monitoring of transplant recipients and for determination of various latent/chronic infections.

· The major problem in clinical transplantation is the overcoming of an acute and or chronic immune-mediated allograft rejection. Pre and post transplant monitoring of cellular immunity with the Enzyme Linked ImmunoSpot (ELISpot) assay has been shown to be useful in predicting longterm outcomes of transplant recipients as well as monitoring of a possible reactivation of latent CMVor EBV infection.
· A.I.D. has developed a combined tool which simultaneously allows to detect latent viral infections, to predict the possible outcome of a planned transplantation and to monitor the patient during time of immunosuppression.

Key Features Determination of latent CMV, BK, and EBV infection Monitoring of CMV, BK and EBV-specific T-cell response Exclusion of Chronic HCV infection Prognostic information from incubation of donor & recipient PBMCs Technical Specifications To view the full technical specifications for the TranSpot ELISpot assay, simply download the PDF below, or return to our full list of products.